1. Home
  2. SHFS vs PHGE Comparison

SHFS vs PHGE Comparison

Compare SHFS & PHGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SHFS
  • PHGE
  • Stock Information
  • Founded
  • SHFS 2015
  • PHGE 2015
  • Country
  • SHFS United States
  • PHGE Israel
  • Employees
  • SHFS N/A
  • PHGE N/A
  • Industry
  • SHFS Finance: Consumer Services
  • PHGE Biotechnology: Pharmaceutical Preparations
  • Sector
  • SHFS Finance
  • PHGE Health Care
  • Exchange
  • SHFS Nasdaq
  • PHGE Nasdaq
  • Market Cap
  • SHFS 22.4M
  • PHGE 26.5M
  • IPO Year
  • SHFS N/A
  • PHGE N/A
  • Fundamental
  • Price
  • SHFS $0.43
  • PHGE $0.54
  • Analyst Decision
  • SHFS
  • PHGE Strong Buy
  • Analyst Count
  • SHFS 0
  • PHGE 2
  • Target Price
  • SHFS N/A
  • PHGE $22.50
  • AVG Volume (30 Days)
  • SHFS 192.2K
  • PHGE 165.9K
  • Earning Date
  • SHFS 11-12-2024
  • PHGE 11-14-2024
  • Dividend Yield
  • SHFS N/A
  • PHGE N/A
  • EPS Growth
  • SHFS N/A
  • PHGE N/A
  • EPS
  • SHFS 0.11
  • PHGE N/A
  • Revenue
  • SHFS $15,855,936.00
  • PHGE N/A
  • Revenue This Year
  • SHFS N/A
  • PHGE N/A
  • Revenue Next Year
  • SHFS N/A
  • PHGE N/A
  • P/E Ratio
  • SHFS $3.76
  • PHGE N/A
  • Revenue Growth
  • SHFS 10.64
  • PHGE N/A
  • 52 Week Low
  • SHFS $0.30
  • PHGE $0.48
  • 52 Week High
  • SHFS $1.55
  • PHGE $8.55
  • Technical
  • Relative Strength Index (RSI)
  • SHFS 55.87
  • PHGE 29.71
  • Support Level
  • SHFS $0.30
  • PHGE $0.48
  • Resistance Level
  • SHFS $0.49
  • PHGE $0.79
  • Average True Range (ATR)
  • SHFS 0.06
  • PHGE 0.09
  • MACD
  • SHFS 0.01
  • PHGE -0.02
  • Stochastic Oscillator
  • SHFS 66.49
  • PHGE 19.52

About SHFS SHF Holdings Inc.

SHF Holdings Inc is a financial services provider to cannabis-related businesses. It offers reliable access to banking solutions for cannabis, hemp, CBD, and ancillary operators, making communities safer, driving growth in local economies, and fostering long-term partnerships. The group, through its financial institution clients, implements accountability, transparency, monitoring, reporting, and risk mitigation measures while meeting Bank Secrecy Act obligations in line with FinCEN guidance on cannabis-related businesses. Its services include Program Management Support, Customer Generation, Ongoing Program Auditing, and Compliance Monitoring among others.

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

Share on Social Networks: